Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02082275 · ClinicalTrials.gov registry record · NA

OB Nest; Redefining Continuity of Care for Expectant Mothers

A NA study, sponsored by Mayo Clinic.

Completed
Registry status
NA
Development phase
300
Enrollment target

NCT02082275: Completed NA study, sponsored by Mayo Clinic.

NCT02082275 is a NA study that has completed, run by Mayo Clinic. The registered enrollment target is 300 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (79% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT02082275, a NA study, has completed, sponsored by Mayo Clinic.

COMPLETED
Registry status
NA
Development phase
300 participants
Enrollment target

Study Summary

The study defines a new model of prenatal care called OB Nest which will be compared to the traditional model of prenatal care. OB nest is intended to create an experience for patients that feels more connected and patient-centered, allowing the patient to visit the clinic less frequently while offering increased communication with the OB nurses and providers through new tools provided to the patient. The goal of the project is to promote patient-centered care through a new prenatal care program based on constant and direct support from a nursing team, meeting the on-demand needs of expecting mothers as they rise, and as thus, redesigning the need and timing of on-site appointment with providers. Pregnant women randomized to the OB Nest cohort will see the number of pre-planned visits with their providers decreased and replaced with more direct and constant support and interaction with an assigned nursing team.

Primary Outcome

At 36 weeks the expectant mother will complete a survey that assessed their satisfaction of the prenatal care received using a validated scale.

Interventions

  • OTHER OB Nest

Trial Details

FieldValue
Enrollment Target 300 participants
Start Date 2014-02
Est. Completion 2015-11
Phase NA
Mayo Clinic

2,844 total trials

What the finished NCT02082275 record still lists

NCT02082275 is an interventional study that assigns participants to a tested intervention. The registered 300 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (79% lower).

The record links to 0 conditions, and to 1 intervention - of which OB Nest is the first listed.

NCT02082275 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02082275 about?

NCT02082275 is a clinical study titled "OB Nest; Redefining Continuity of Care for Expectant Mothers". The study defines a new model of prenatal care called OB Nest which will be compared to the traditional model of prenatal care. OB nest is intended to create an experience for patients that feels more connected and patient-centered, allowing the patient to visit the clinic less frequently while offe...

What is the current status of trial NCT02082275?

This trial is currently completed. It is a NA study. The enrollment target is 300 participants. The study started on 2014-02. Estimated completion is 2015-11.

What interventions are being tested in trial NCT02082275?

The interventions under investigation include: OB Nest (OTHER).

Who is sponsoring clinical trial NCT02082275?

This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02082275's enrollment target sits among peer trials

300 330th of 2000 higher than 1,630 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00353483 · 300 participants

    Effect of Neoadjuvant or Adjuvant Systemic Therapy on Breast Cancers, Bone Marrow Cancer Cells, and Circulating Cancer Cells

  • NCT00588185 · 300 participants · NA

    [18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate Cancer

  • NCT00682032 · 300 participants · NA

    The Effect of Beta-glucan in Non-Small Cell Lung Cancer

  • NCT00870064 · 300 participants · NA

    The Treatment of Type I Open Fractures in Pediatrics

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02082275, the US trial registry maintained by the National Library of Medicine. NCT02082275 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.